重新思考经皮冠状动脉介入治疗:超低对比剂介入时代
本文综述了超低对比剂经皮冠状动脉介入治疗(ULC-PCI)的证据、操作流程与临床意义。ULC-PCI 整合血管内影像、生理学指导和动态冠脉路图等技术,在维持操作质量的同时减少对比剂暴露。其推广需结构化培训及进一步结局验证。
要点
- ULC-PCI 旨在降低慢性肾脏病患者对比剂相关急性肾损伤风险。
- 可整合 IVUS/OCT、FFR/iFR 和动态冠脉路图减少对比剂用量。
- 推广 ULC-PCI 需要结构化培训和进一步临床结局验证。
核心结论
- ULC-PCI 代表向更安全、精准指导的血运重建模式的转变。
研究设计与样本
- 本文为综述,回顾了近期关于对比剂减少策略、影像与生理学指导 PCI 及相关临床结局的文献。
主要发现
- ULC-PCI 通过血管内影像、生理学评估和动态冠脉路图技术安全减少对比剂暴露。
临床怎么用
- 在 PCI 中可考虑采用 ULC-PCI 技术流程以降低高危患者对比剂相关肾损伤风险。
局限性
- 更广泛的实施需要结构化培训和进一步结局验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Iodinated contrast remains a key component of percutaneous coronary intervention, yet it poses a significant risk for contrast-associated acute kidney injury (CA-AKI), particularly in patients with chronic kidney disease (CKD). This review summarizes the evidence, procedural workflow with stepwise approach including clinical implications of ultra-low-contrast PCI (ULC-PCI). We reviewed recent literature describing strategies for contrast reduction, imaging and physiology-guided PCI, and subsequent clinical outcomes. ULC-PCI incorporates techniques such as intravascular imaging (IVUS/OCT), fractional flow reserve (FFR/iFR), and dynamic coronary roadmap imaging to safely reduce contrast exposure while maintaining procedural quality. It, thus, represents a paradigm shift toward a safer, precision-guided revascularization. Broader implementation requires structured training in this aspect and further outcome validation.
引用
- Catheterization and Cardiovascular Interventions:Rethinking Percutaneous Coronary Intervention: The Era of Ultra‐Low‐Contrast Intervention
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。